Your browser doesn't support javascript.
loading
Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding.
D'Angelo, Sara; Ferrara, Fortunato; Naranjo, Leslie; Erasmus, M Frank; Hraber, Peter; Bradbury, Andrew R M.
Affiliation
  • D'Angelo S; Specifica Inc., Santa Fe, NM, United States.
  • Ferrara F; Specifica Inc., Santa Fe, NM, United States.
  • Naranjo L; Specifica Inc., Santa Fe, NM, United States.
  • Erasmus MF; Specifica Inc., Santa Fe, NM, United States.
  • Hraber P; Los Alamos National Laboratory, Los Alamos, NM, United States.
  • Bradbury ARM; Specifica Inc., Santa Fe, NM, United States.
Front Immunol ; 9: 395, 2018.
Article in En | MEDLINE | ID: mdl-29568296
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Heavy Chains / Complementarity Determining Regions / Single-Chain Antibodies / Antibody Diversity Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2018 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Heavy Chains / Complementarity Determining Regions / Single-Chain Antibodies / Antibody Diversity Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2018 Document type: Article Affiliation country: United States Country of publication: Switzerland